(Press-News.org) SAN ANTONIO, March 26, 2024 – Thomas Patterson, MD, and David Gius, MD, PhD, two top physician-scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), have been accepted into the prestigious Association of American Physicians for the advancement of scientific and practical medicine.
Patterson is professor of medicine and chief of the Division of Infectious Diseases and vice chair for clinical research for the Department of Medicine in the Joe R. and Teresa Lozano Long School of Medicine, and Gius is associate cancer director of translational research at the Mays Cancer Center and assistant dean of research and professor of radiation oncology in the Long School of Medicine.
Election to the AAP is an honor extended to physicians with outstanding credentials in basic or translational biomedical research and is limited to only 70 persons per year. Patterson and Gius will be recognized during the AAP annual meeting at a dinner in Chicago on April 6.
“This is a significant recognition as the AAP is one of the country’s oldest and most prestigious physician-scientist honor societies,” said Robert A. Hromas, MD, FACP, acting president of UT Health San Antonio.
“Dr. Patterson is a distinguished leader in the study, diagnosis and treatment of fungal diseases, particularly in immunocompromised hosts, and Dr. Gius is preeminent in research of the relationship between aging, mitochondrial bioenergetics and breast cancer,” Hromas said. “We join in congratulating them both on this richly deserved honor.”
With his extensive experience in the study of opportunistic fungal infections, Patterson has been involved in developing new antifungal drugs and in clinical trials of new antifungal compounds. He also is director of the San Antonio Center for Medical Mycology.
He has published and lectured widely on fungal infections and was an early founder and co-editor-in-chief of the popular mycology website DoctorFungus (www.drfungus.org). During the COVID-19 pandemic, Patterson led the UT Health San Antonio Division of Infectious Diseases’ efforts in clinical management of COVID-19 care and was the institution’s principal investigator for the Adaptive COVID-19 Treatment Trial (ACTT) conducted at University Hospital, supported by the National Institutes of Health to develop safe and effective therapies against COVID-19.
He is a principal investigator for the RECOVER study to combat Long COVID. He is a fellow of the American College of Physicians and past president of the Texas Infectious Disease Society and the International Immunocompromised Host Society.
He received his Bachelor of Arts degree from Baylor University and his medical degree from McGovern Medical School in Houston. He completed his internship and residency at Vanderbilt University Medical School and at Yale-New Haven Hospital, and a fellowship in infectious diseases at Yale University School of Medicine, where he also served as an assistant professor of medicine.
Gius was recruited in 2020 to UT Health San Antonio from the Robert H. Lurie Comprehensive Cancer Center at Northwestern University with a grant award by the Cancer Prevention and Research Institute of Texas. The following year, he earned a $1.6 million UT System Faculty STARs award to support his research on aging and breast cancer.
Gius graduated from the University of Illinois with a Bachelor of Science degree in chemistry, finished his PhD thesis work from the University of Chicago and graduated from Loyola Medical School. He completed an internship year at the University of Michigan and a radiation oncology residency at Washington University School of Medicine, the Mallinckrodt Institute of Radiology.
He was an assistant professor at Washington University for four years and then accepted a position as the chief of the Molecular Radiation Oncology Section at the National Cancer Institute in the Radiation Oncology Branch that lasted nine years.
At Northwestern, he was the Zell Family Scholar Professor and director of the Women’s Cancer Research Program at the Lurie Comprehensive Cancer Center, and vice chairman of the Translation Research Department of Radiation Oncology and Pharmacology at the Feinberg School of Medicine.
AAP is an honorary medical society founded in 1885 by the Canadian physician Sir William Osler and six other distinguished physicians of his era for “the advancement of scientific and practical medicine.” The organization includes more than 1,800 active members and 750 emeritus and honorary members. The great majority are U.S. citizens though other countries also are represented.
The overarching goals of the AAP include the promotion of professional and social interaction among biomedical scientists, the dissemination of important information related to biomedical science and teaching, the recognition of outstanding, diverse physician-scientists through membership and the establishment of role models to kindle new generations of high achievers in medicine and medical science.
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) is one of the country’s leading health science universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions, graduate biomedical sciences and public health have graduated more than 42,550 alumni who are leading change, advancing their fields and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways “We make lives better®,” visit UTHealthSA.org.
Stay connected with The University of Texas Health Science Center at San Antonio on Facebook, Twitter, LinkedIn, Instagram and YouTube.
The UT Health San Antonio Joe R. and Teresa Lozano Long School of Medicine is listed among U.S. News & World Report’s best medical schools, ranking in the top 30% nationwide for research. To learn more, visit https://uthscsa.edu/medicine/.
The Mays Cancer Center at UT Health San Antonio is one of only four National Cancer Institute-designated Cancer Centers in Texas. The Mays Cancer Center provides leading-edge cancer care, propels innovative cancer research and educates the next generation of leaders to end cancer in South Texas. To learn more, visit https://cancer.uthscsa.edu.
Stay connected with the Mays Cancer Center on Facebook, Twitter, LinkedIn, Instagram and YouTube.
The Sam and Ann Barshop Institute for Longevity and Aging Studies is one of the world’s premier institutes dedicated to the study of age-related diseases. The Barshop Institute is the only aging-intensive research institute in the country to have four peer-reviewed designations: two National Institute on Aging (NIA)-funded centers (Nathan Shock and Claude D. Pepper centers), a testing site of the NIA-sponsored Interventions Testing Program, and a U.S. Department of Veterans Affairs Geriatric Research, Education and Clinical Center.
END
Drs. Thomas Patterson, David Gius accepted into the prestigious Association of American Physicians
2024-03-26
ELSE PRESS RELEASES FROM THIS DATE:
Taming the beast: FAMU-FSU researcher controls voltage response for safer electric grid
2024-03-26
When FAMU-FSU College of Engineering Professor Fang Peng was a boy, he saw the power and peril of electricity firsthand.
He was in middle school when his remote Chinese hometown first received electric service. His family shared a single portable, 15-watt light bulb attached to a cable. It was his job to replace the bulb.
“One night, the bulb went out and I tried to change it in total darkness,” Peng said. “I accidentally stuck my left thumb in the socket and was immediately shocked. I got knocked off balance and down to the dirt floor, trembling as the electricity seared through my body. Luckily, my right ...
Professor Bruce Freeman: Keynote Speaker of the 26th International Conference of the Redox Medicine Society
2024-03-26
Bruce A. Freeman, Irwin Fridovich Distinguished Professor and Chair at the University of Pittsburgh School of Medicine Department of Pharmacology & Chemical Biology, will introduce Redox Medicine 2024 with a key note talk titled "Small Molecule Electrophiles: Lessons from a Journey through Studying the Redox Chemistry of Nitrogen Oxides to Drug Development”.
The 26th International Conference of the Redox Medicine, Redox Medicine 2024, will take place on June 27-28 at Fondation Biermans Lapôtre in Paris, France.
Professor Freeman will discuss the generation and actions of nitrogen oxide-derived fatty acid nitroalkenes in the context of ...
Penn Medicine study reveals inequities in access to transformative CAR T cell therapy
2024-03-26
PHILADELPHIA – Patients being treated for B-cell non-Hodgkin’s Lymphoma (NHL) who are part of minority populations may not have equal access to cutting-edge CAR T cell therapies, according to a new analysis led by researchers from the Perelman School of Medicine at the University of Pennsylvania and published today in NEJM Evidence.
CAR T cell therapy is a personalized form of cancer therapy that was pioneered at Penn Medicine and has brought hope to thousands of patients who had otherwise run ...
Artificial reef designed by MIT engineers could protect marine life, reduce storm damage
2024-03-26
The beautiful, gnarled, nooked-and-crannied reefs that surround tropical islands serve as a marine refuge and natural buffer against stormy seas. But as the effects of climate change bleach and break down coral reefs around the world, and extreme weather events become more common, coastal communities are left increasingly vulnerable to frequent flooding and erosion.
An MIT team is now hoping to fortify coastlines with “architected” reefs — sustainable, offshore structures engineered to mimic the wave-buffering effects of natural reefs while also providing pockets for fish and other marine ...
Biotechnology CEO and inventor of SiriusXM Satellite Radio Martine Rothblatt to deliver graduation address to the University of Maryland School of Medicine’s 215th graduating class
2024-03-26
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Martine Rothblatt PhD, JD, MBA, Chairperson and CEO of United Therapeutics, and inventor of SiriusXM Satellite Radio, will deliver the keynote address for this year’s graduating medical student class. The UMSOM MD graduation ceremony will take place at the Hippodrome Theatre on Thursday, May 16, 2024. The ceremony will begin at 1:00 pm. Details for faculty members are here. Details for students/guests are here.
Dr. Rothblatt is a trailblazing pioneer of several innovations in biotechnology, pharmaceuticals, and satellite communications. After developing SiriusXM, ...
ORIGAMI: anticipating the future of more connected, efficient and sustainable telecommunication infrastructures
2024-03-26
The ORIGAMI (Optimized Resource Integration and Global Architecture for Mobile Infrastructure for 6G) project is now underway. The project, funded by the European Commission under the Horizon Europe program, will spearhead architectural innovations for the next generation of 6G mobile networks, to enable innovative applications, new business models, and substantial reductions in energy consumption.
By proposing and developing three critical architecture innovations – Global Services Based Architecture (GSBA), Zero Trust Exposure Layer (ZTL), and Continuous Compute ...
Study says it’s time to highlight positive skills associated with neurodevelopmental conditions
2024-03-26
New research says the wide variety of skills displayed by people with conditions such as ADHD, dyslexia and autism should be celebrated to help reduce stigma and change society’s expectations.
Creativity, resilience and problem-solving are just some of the strengths exhibited and a study is now calling for a change in the way we think about people with neurodevelopmental conditions.
Dr Edwin Burns, senior lecturer from the School of Psychology at Swansea University, worked with academics from Edge Hill University on the study and their findings have just been published by ...
Corporations use government grants to lighten debt load
2024-03-26
Local and state governments have a variety of tools at their disposal to attract businesses or entice them to stay. One is tax relief. Austin, for example, helped lure electric automaker Tesla in part with property tax rebates worth $14 million over 10 years.
In a study released today from Texas McCombs, Dean and Accounting Professor Lillian Mills finds that another kind of government aid — cash grants — has a different kind of impact. It helps companies lighten their balance sheets by borrowing less.
Corporations ...
C-Path launches consortium for alpha-1 antitrypsin deficiency
2024-03-26
TUCSON, Ariz., March 26, 2024 — Critical Path Institute (C-Path) is excited to announce the launch of the Critical Path for Alpha-1 Antitrypsin Deficiency (CPA-1) Consortium. The CPA-1 consortium aims to accelerate drug development for alpha-1 antitrypsin deficiency (AATD), a rare disease that affects individuals and families worldwide. This will be achieved by integrating data through C-Path’s Rare Diseases Cures Accelerator–Data Analytics Platform (RDCA-DAP®) and leveraging those data for CPA-1 to collaboratively develop regulatory-grade solutions to continuously address unmet needs in drug development for this condition, including:
Generating evidence to ...
In paleontology, correct names are keys to accurate study
2024-03-26
COLUMBUS, Ohio – When the skeletal remains of a giant ground sloth were first unearthed in 1796, the discovery marked one of the earliest paleontological finds in American history.
The animal, named Megalonyx by Thomas Jefferson in 1799, was the first genus of fossil named from the United States. Thought to have roamed North America during one of the last ice ages, the extinct giant ground sloth was an herbivorous mammal resembling a large bear — at full size, it likely reached nearly 10 feet tall (3 meters) and weighed about as much as a small elephant.
The report made by Jefferson, an avid fossil collector who was known to keep ...